SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-23-027549
Filing Date
2023-05-04
Accepted
2023-05-04 21:58:39
Documents
2
Period of Report
2023-05-03

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 8819
2 POA DOCUMENT poa.txt EX-24 3078
  Complete submission text file 0001209191-23-027549.txt   13265
Mailing Address C/O SGX PHARMACEUTICALS, INC. 10505 ROSELLE STREET SAN DIEGO CA 92121
Business Address
GREY MICHAEL G (Reporting) CIK: 0001240122 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38981 | Film No.: 23891014

Mailing Address 950 TOWER LANE, SUITE 1050 FOSTER CITY CA 94404
Business Address 950 TOWER LANE, SUITE 1050 FOSTER CITY CA 94404 650-667-4085
Mirum Pharmaceuticals, Inc. (Issuer) CIK: 0001759425 (see all company filings)

IRS No.: 831281555 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations